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INTRODUCTION
BACKGROUND
Tuberculosis is one of the oldest diseases known to affect man. It  is the third most
common cause of death worldwide. Every year, more than 9 million people are
affected with tuberculosis (TB). Out of which 1.5 million deaths are reported per
annum, which contributes to the vast majority of deaths in the developing world.
One out of  three in this world are affected with latent TB; which has a lifelong
risk of accquiring active TB.
Around 350 millio people are Diabetes .The prevalence of which is similar in
both developed and developing countries. Around Eighty percentage ( 80% ) of
deaths due to diabetes is seen in in lowand middle income countries. Estimation
made that Universal Diabetes prevalence rise by 50% by 2030.
 People with chronic diseases such as diabetes are immune deficient so there
is  increased risk of progressing from latent to active TB.
 Diabetics have a 2-3 times increased risk of TB compared to non-diabetics.
 Around 10% of TB cases globally are found to be associated with diabetes.
 Huge  percentage of people who have diabetes and TB are either not
diagnosed or diagnosed too late. Early diagnosis will helps in improve care
and control of both.
 Each TB patients should be screened for diabetes.
( WHO Recommendation )
 In high prevalent areas screening for TB in  diabetic patients should be
considered as a priority ( WHO Recommendation ).
 Diabetics diagnosed with TB have a greater risk of death at the time of TB
treatment or due to TB relapse after completion of treatment.
 Teatments should be adequately emphasized for both TB and diabetes.
AIM OF THE STUDY
 To  Study the prevalence of Tuberculosis among Diabetic patients.
 To study the pattern, presentation of tuberculosis and the factors
influencing the prevalence among Diabetic patients.
REVIEW OF LITERATURE
Diabetes mellitus encloses a group of common metabolic disorders
that have the common phenotype of hyperglycemia.
Diabetes mellitus is sub divided on the basis of the pathological process that leads
to hyperglycemia
Classification
Type 1 Diabetes Mellitus
Type 1 A : Diabetes mellitus occurs due to autoimmune β cell destruction, which
leads to insulin deficiency.
Type 1 B : Diabetes mellitus patients lack immunologic markers that signifes an
autoimmune mediated destruction of β cells. Insulin deficiency in them occurs by
un known mechanisms and they are more prone for developimg ketosis.
Type 2 Diabetes Mellitus
It encloses insulin resistance; increased glucose production, impaired
insulin secretion. Both metabolic and genetic defects contribute for the
development of common phenotype of hyperglycemia.
Other Specific Types of Diabetes Mellitus
1. Diseases of exocrine pancreas – pancreatitis, pancreatectomy, neoplasia etc.
2. Endocrine disorders – acromegaly, cushing’s syndrome, glucagonoma, etc.
3. Drug or chemical induced – vacor, pentamidine
4. Infections – CMV, congenital rubella, coxsackie.
5. Genetic syndromes . – Turners, Down’s syndrome, klinefelter syndrome,
Wolfram’s, etc.
6. Genetic defects of β cell functions with certain mutations.
Gestational Diabetes Mellitus
Maturityonset diabetes of the young (MODY)- characterized
by Autosomal dominant inheritance, impairment of  insulin production and early
onset hyperglycemia.
Symptoms
 Polydipsia .
 Polyuria
 Polyphagia
 Fatiguability, irritability
 Weight loss/gain
 Blurring of vision
 Pruritis vulvae, balanitis
 Nausea, headache
Poorly controlled diabetes are associated with higher risk for
infection and patients are prone to develop skin sepsis (boils) and genital-
candidiasis and pruritis vulvae or balanitis.
Patients with type 2 DM have various clinical signs . More than 70% are over
weight, and Obesity  less common - developing countries. Hypertension is present
in 50% of patients with type II diabetes mellitus.
Diagnosis
The National Diabetes Data Group and World Health Organization (WHO) on the
basis of  the spectrum of Fasting plasma glucose (FPG) and the response to an oral
glucose load has issued a diagnostic criteria for diabetes mellitus.
.
Criteria for the diagnosis of DM:
 Symptoms of diabetes plus random blood glucose concentration(RBS)
≥200 mg/dl or
 Fasting plasma glucose (FPG) ≥ 126 mg/dl or
 2 hour plasma glucose(PG) ≥ 200 mg/dl during an oral glucose tolerance
test.
Glucose tolerance is subdivided into three ( 3) groups on basis of FPG.
 (FPG ) < 100 mg/dl is considered as normal.
 (FPG) ≥ 100 mg/dl but (FPG )< 126 mg/dl - as Impaired fasting Glucose
 (FPG) ≥ 126 mg/dl- indicative of diabetes mellitus.
IGT - explained by the criteria as plasma glucose levels in persons between -
140 & 200 mg/dl- 2 hours after a 75 g oral glucose load.
Persons with IFG or IGT are at risk to develop - type 2 diabetes mellitus (>40%
risk over the next five years) and coronary artery disease.
DIABETES AND INFECTION
Before the introduction  of modern antimicrobial therapy,
infection accounts for most of the mortality in diabetes. In the pre insulin era (from
1914 – 1922, 17.6% ) of death among diabetic patients were reported due to
infection. With the advent of chemotherapeutic and antimicrobial agents, fewer
and fewer deaths were considered to be due to infection. As for as morbidity is
concerned, diabetic patients are particularly more susceptible to respiratory tract
infection,urosepsis and dermatological manifestation
FACTORS CONTRIBUTING TO INFECTION
With good control of diabetes, resistance to
infection, seems to be normal. . If blood sugar is controlled poorly ,for eg. in the
presence of diabetic ketoacidosis, the resistance is lowered due to impaired
leukocyte function. In 1960, there was a report done by Priscilla White regarding
478 patients who lived 30 or more years with juvenile diabetes had high incidence
of infections skin infection 55%, urinary tract infection in 28%, pulmonary
tuberculosis in 6%
BLOOD GLUCOSE EFFECT ON INFECTION
In beginning of 20th century Lassar postulated that” infections
were more Prevalent among diabetics because bacteria thrive in a high glucose
medium”. Recent studies confirmed that some gram positive cocci prefer high
concentration of glucose for growth. There is a definite correlation between
presence of infection and mean level of plasma glucose.
Diabetes Mellitus, is said to be a secondary immune deficiency
disorder by WHO, as the disease has the following characters:
1.Causes recovery when once the underlying disease is treated
2.  Recurrent, extensive and chronic infections.
3.  Cause impairment of atleast one  defence mechanism (e.g.polymorphonuclear
leucocytes or lymphocyte response), that results in acquiring infection .
ALTERED IMMUNE MECHANISM IN DIABETES MELLITUS
CHEMOTAXSIS:
Chemotaxsis is process , in which polymorpho/nuclearcells migrate to the site of
infection as a response to chemotactic substances secreted by microorganisms. In
DM patients, there is a diminished chemotaxis has seems to be correlates well
with the glycemic status of the patients.
PHAGOCYTOSIS:
phagocytosis is impaired in long standing uncontrolled
diabetics,and it is associated with intrinsic defect of polymorphs due to-increase in
sialidase enzyme production  and decrease in the sialic acid .when sugar is high it
saturates lectin receptors and it fails to initiate phagocytosis.
KILLING ACTIVITY:
Killing activity  are due to lysosomal enzymes, from the
polymorphs after the formation of phagolysosome and it  is due to both
oxid’ative and nonoxidative metabolism. Uncontrolled blood sugar results in
impairment of killing activity and its  killing activity is regained once  the insulin
therapy is started.
.
Lymphocyte Function:
In type 1 diabetes, there will be decreased no of
lymphocytes, especially of (CD4helper cells) and it may occurs due to decrease in
insulin secretion or due to inefficacy. Normalization of blood sugar will reverses
this effect. Due to deficiency ofCD4,the individuals exhibit impairment in the
antibody production against viral infection-eg.Hepatits b
IMMUNOGLOBULINS:
In Diabetic patients low level of Ig particularly IgG and IgA are seen
COMPLEMENT
In Type 1 diabetes mellitus, 25 % of cases found to have decreased
C4 levels in relation with C4A null gene . Impairment or defect in other
complements like C3 and C1q are also associated with diabetes
Is  Local causes plays a significant role in infection in diabetics ?
1. Hyperglycemia- causes dysfunction of endothelium and oxidative stress
which plays a significant role in fungal and bacterial infection
2. Micro and Macrovascular causes anoxia and it results in proliferation of
micro organism, which impairs the  oxygen (02) dependent PMN
(polymorphonucleocytes) function and impairs the functions of antimicrobial
drugs.
ENDOCRINE SYSTEM INFLUENCE ON INFECTION:
The relationship of diabetes to endocrine glands other than the pancreas and
the role of other hormones apart from insulin in host resistance to infection are
extremely important. The anti-inflammatory effect of adrenal steroids attributed to
 decreased permeability of microvasculature,
 diminished antibody response and
 altered function of the reticuloendothelial system.
The precise role of thyroid hormones is not fully worked out.
Vascular Insufficiency:
Impairment in circulation contributes to significant level for infection of foot. The
normal response to infection is increased local circulation. The response in the
presence of vascular insufficiency is thrombosis and necrosis. It can lead to
arteriosclerotic gangrene.
Effect of Malnutrition:
In diabetics, there is some degree of malnutrition at the cellular
level due to metabolic effects. Perhaps the hepatic dysfunction with its consequent
hypovitaminosis contributes for causation of pulmonary tuberculosis among
diabetics. Depletion of liver glycogen content may play a role in increased
intensity
INFECTIVE COMPLICATIONS OF DIABETES MELLITUS:
Urinary tract infections: Urinary tract infections in diabetics include
 Aymptomatic bacteriuria,
 pyelonephritis,
 cystitis.
 Less common infections are perinephric abscess, renal papillary necrosis
secondary to infection, renal tuberculosis and emphysematous
pyelonephritis.
 Skin Infections: Diabetics are more prone to skin infection, particularly
those caused by staphylococcus aureus are common in poorly controlled
diabetics. These are probably due to number of factors including
 peripheral neuropathy and
 peripheral vascular disease.
Other Infections:
 Osteomyelitis
 Periodontal infection
 Postoperative infection
 Bacterial pneumonia
 Septicemia
Infections peculiar in diabetes are:
 Mucormycosis
 Malignant otitis externa
 Emphysematous cholecystitis
 Necrotizing cellulitis and fascitis
Management of Diabetes :
 For the control of diabetes when it is associated with pulmonary
tuberculosis, insulin is the main stay of treatment.Nowadays DNA
recombinant technology is used for the production of insulin.
Insulin preparations available:
Ultra short :
 Lispro
 Insulin aspart
Short acting
 Regular
Intermediate acting
 NPH
 Lente
Long acting
 Ultra lente
 Glargine
Combinations
 70/30 – 70% NPH, 30% regular
 50/50 – 50% NPH, 50% regular
 Insulin Regimens :
 In all regimens, intermediate or long acting insulins (NPH, Lente,
Ultralente) supply basal insulin, whereas regular, insulin aspart or lispro
provides prandial insulin.
One popularly used regimen consists of an intermediate acting
insulin (NPH or lente) given as twice daily injections mixed with a short acting
insulin before the morning and evening meal. Such regimens usually prescribe 2/3
of the total daily insulin dose in the morning (with about 2/3 given as intermediate
acting and 1/3 as short acting) and 1/3 dose before the evening meal (with
approximately one half given as intermediate acting and one half as short acting).
Oral hypoglycemic agents  in Type-II Diabetes
1. Insulin secretagogues: Insulin secreatogogues act by ↑ insulin secretion .
Mechanism of action is to act on ATP sensitive potassium channels in β cells of
pancreas.  These drugs are efficient in individuals with type 2 diabetes mellitus of
recent onset (< 5 years), who tends to be obese and have residual endogenous
insulin production.
Example: Sulfonylureas
- Glibenclamide.
- Glimepride
- Glipizide
- Glyburide
Insulin secretagogues: Nonsulfonylurea-↑ Insulin secretion- Nateglinide,
repaglinide,mitiglinide
2. Biguanides: It cause reduction in glucose formation in the liver and it increases
the peripheral need for blood glucose .
Example: Metformin
FPG and insulin levels are reduced by biguanides  that  improves the
dyslipidemia (lipid profile),and had neutal effect on weight. Dose 500 – 3000 mg
once or twice daily.
2. Alpha Glucosidase Inhibitors: They reduce postprandial hyperglycemia by
decreasing the rate of (absorption of glucose).
Example: Acarbose
Miglitol
Therapy should be initiated at a low dose (25 mg of Acarbose or Miglitol)
with the evening meal and may be increased to a maximal dose over weeks
to months. Adverse effects (diarrhoea, flatulence, abdominal ldistention) is
due to increase in delivery of oligosaccharides to the large bowel.
4. Thiazolidinediones: It reduces insulin resistance and increases glucose
utilisation
Example: Pioglitazone: 15 – 45 mg/day single daily dose
Rosiglitazone: 2 – 8 mg/day
5.Sodium-glucose2 inhibitors-acts by ↑ Urinary glucose excretion -examples
Canagliflozin, dapagliflozin, empagliflozin
6.Dipeptidyl peptidase IV inhibitors-acts by Prolonging endogenousm GLP-1
action eg.Alogliptin,Anagliptin,Gemigliptin, linagliptin,saxagliptin,
sitagliptin, teneligliptin, vildagliptin.
7.GLP-1 receptor agonists- acts by ↑ Insulin & ↓ glucagon,secretion,slows gastric
emptying, satiety ex .Exenatide, liraglutide, dulaglutide
Insulintherapy in Type 2 diabetes:
Insulin used as first line in therapy in type 2 diabetes, in following
conditions
 hospitalized / acutely ill patients
 patients having loss of weight,
 Renal or Liver disease
Insulin is usually initiated in a single dose of intermediate or long acting
insulin (0.3 – 0.4units/kg/day) given either before breakfast or just before
bed time. Insulin can be used in combination with any of the oral agents in
patients who fail to reach the glycemic target. The daily insulin dose
required can become quite large (1 – 2 unit/kg/day) as endogenous insulin
production falls and insulin resistance persists. Patients who require more
than 1 unit/kg/day of intermediate acting insulin should be considered for
combination therapy (Metformin or Thiazolidinedione) can reduce insulin
requirement in patients with type 2 diabetes.
HISTORICAL BACKGROUND OF PULMONARY TUBERULOSIS
Tuberculosis has been in existence through the ages. There is
evidence to show that it was prevalent even in the prehistoric times in the neolithic
and Paleolithic era. Sushrutha describe the disease and had found that it was
difficult to treat and his treatment was based mainly on hygiene and diet.
Various names had been given to the disease, the most notable
was, Pthisis by Hippocrates. Laennaec described it as tubercle, from which the
present day term of tuberculosis is derived. Rudolf Virchow first described the
development of caseation in tuberculous tissue.
The concept that tuberculosis is infectious was first proved by
Villemin and Koch in the 19th century and was followed by the discovery of the
tubercle bacilli in 1882 by Robert Koch. Flugge in 1887 demonstrated that the
main channel of infection was by inhalation of the bacilli.
With the discovery of X-ray by Roentgen in 1895, radiological
examination became a valuable diagnostic tool. The first significant step in the
treatment of the disease was the sanitorium therapy suggested by George
Bodington. BCG vaccination was introduced as a preventive measure in 1921.
The first specific drug to combat tuberculosis was streptomycin
discovered in 1944 by Waksman. This was followed by PAS, INH and other drugs.
The conquest of tuberculosis will be one of the greatest steps forward for
the attainment of our goal of positive health. The conquest of tuberculosis will be
one of the greatest steps forward for the attainment of our goal of positive health.
Pathology :
Diabetes mellitus, when associated with pulmonary tuberculosis
shows special features of large confluent, sometimes transient infiltrations which
tend to liquify
extensively.
Experimentally, it has been suggested that dogs lose their natural
resistance to tuberculosis after pancreatectomy. Similarly, the natural resistance of
the albino rat is lowered by induced hyperglycemia, the tubercles being more
confluent, more widespread and richer in rats infected with tubercle bacilli than
among controls.
The morphology of lungs in patients with TB and DM showed that the
combined affection is  characterized by aprogressive course of  tuberculosis with
involvement of bronchi. Specific features of tissue reactions pertinent to this
combined pathology comprises of defective defence mechanisms,generalized
affection of pulmonary vessels, intensive fibre formation and disorganization of the
forming connective tissue.
Decreased production of interferon γ by CD4 + T cells plays an important role in
increased susceptibility to infection among diabetics. Tuberculous patients  had
low Interferon γ at diagnosis irrespective of their diabetic status16.
Among diabetic patients, IFN-γ was found to be more lower in
uncontrolled diabetics than in controlled diabetics. After   6 months of treatment
for diabetes , IFN-γ will becomes normal only in those individuals, who had good
glycemic control.
There was higher incidence of sputum positivity and higher
incidence of lung involvement, particularly cavitations in comparison with other
lung changes. Early studies shows that lower lobe involvement is higer among
diabetics but recent studies shows that similar pattern of lung involvement among
diabetics and non-diabetics
Pulmonary Alveolar macrophages (PAM) along with lymphocytes
plays a major role in elimination of mycobacterial infections. Hypodense PAM
(less than 1030 gm/ml) fraction is less in diabetic pulmonary tuberculosis than in
pulmonary tuberculosis alone. PAM in tuberculous patients who are associated
with diabetes mellitus seems to be less activated, and its contributes for the
development of mycobacterial infections.
Factors responsible for increased susceptibility to tuberculosis in diabetics are as
follows:
1. Impairment in the function of Neutrophils.
2. Interleukin1β and TNFα synthesis is reduced more among the Uncontrolled
diabetic patients.
3.Lung capacity, total diffusion capacity and elastic recoil effect of lungs is
decreased due to thickening of alveolar epithelium and basal lamina.
4. Diabetic autonomic neuropathy leads to reduced bronchial dilation and
reactivity.
Relapse rate is more common with resistant strains among diabetics
and has a worse prognosis inspite of similar bacteriological conversion rate among
diabetics and non diabetics.
As patients with poor glycemic control are more prone to
develop tuberculosis, patients affected with TB also have a higher prevalence of
diabetes mellitus with prevalence rate ranging between (1.8 – 40%) in various
studies.
Probable  factors for prevalence of diabetes mellitus in tuberculosis are:
 Reciprocal worsening of disease by each other.
 Malnourishment and low Body Mass Index.
 Pancreatic tuberculosis (rarely).
 Stress induced diabetes mellitus as a result  of tuberculosis.
 Adrenal gland, pituitary- hyperactivity.
 Deficiency of vitamin D
In a study on 927 cases of culture positive tuberculosis, diabetes
mellitus was detected in 12.4 percent of individuals. As shown in the above study
the symptoms of TB are not altered by diabetes. It does not change the drug
response or resistance or distributive pattern of the lesion in the lung.
Lower lung involvement is significantly high among individuals
above 40 years and in female sex. In Tuberculous diabetic patients cavity, opacity
and involvement of pleura were higher in comparison with reticulonodular pattern.
Type 1 diabetics are more prone for cavitating lesions than type 2 diabetic patients
(DM 1> 2). Inspite of higher bacterial population in cavitary lesions less smear
positivity is seen among diabetic patients which can be due to weakness of muscles
caused by poor glycemic control and weak expectoration. Increased incidence of
lower lobe involvement may be due to (1) Increased incidence of primary
tuberculosis or impairment in the immunological status, (2 ) increased oxygen
pressure in lower lobe alveoli. MDR tuberculosis is more common in diabetics
than in non-diabetics.(MDR-Diabetics>Non diabetics)
.Reactivation of the primary or post primary lesion :
In a patients life reactivation can occur at any point of time. Reactivation of
lesion which was acquired many years previously is the  major cause of post
primary pulmonary tuberculosis among adult men/women. Immunosuppression at
any point of time in his/her life can result in post primary PTB.
Steroid and other Immunosuppressant drugs :
Reactivation of TB may occur in patients who has been receiving
corticosteroids or other immunosuppressant drugs for treatment of disease or for
the suppression of transplant rejection.
Immunodeficiency states like acquired immune deficiency syndrome
(AIDS), Hodgkin’s disease, leukemia & lymphoma increase the susceptibility to
reactivation.
Smear positivity and predisposition to tuberculosis is more among
diabetics.
Incidence ofTube rculosis
Diabetics are 5-10 times more prone for infection with TB which is
usually asymptomatic and diagnosed late and is commonly because of reactivation
of latent infection.
Reasons for incidence of tuberculosis is more common in diabetes?
Probable reasons are:
 Hyperglycemia favours the growth, viability and propagation of tuberculosis
bacilli.
 Decreased opsonic index.
 Pituitary or adrenocortical hyperactivity.
 Hypovitaminosis A and C.
 . Impaired phagocytosis.
 Decreased neutralising antibody in bronchial secretions.
 Decreased resistance -due to vascular damage to lung tissue.
Pecularities of Tuberculosis in DM
Unique features of TB in diabetics:
 Relative absence of symptoms and diagnosed at late stage.
 Cavitary lesions with caseation are more in number.
 Minimal involvement of pleura.
 Have increased hemoptysis.
 Decreased incidence of extra pulmonary and endobronchial tuberculosis.
 Higher smear positivity.
In a study done on 2434 cases of pulmonary
tuberculosis, it showed that 62.8% were males and 37.2% were females and 39.7%
were in age group 45 years and above. There were 138 cases of diabetes, 100 were
males and 38 were females.
Prevalence in males was 6.4% and in females 4.3%.
Most of the diabetic cases were in the age of 45 years and above (82.6%) .
In 4349 cases of diabetes studied between 1967 and 1974,
179 cases were found to have pulmonary tuberculosis. 135 cases were males and
44 were females. Maximum cases occurred in age groups of 50-60 years25.
Research Committee of the Tuberculosis Association of
India conducted a study in 7 centers in India. It consisted of 935 pulmonary
tuberculosis patients and 9.7% had diabetes. Of the 602 patients in the age group
less than 40 years, 29 had diabetes mellitus (4.8%). Of the 333 patients belonging
to greater than 40 years, 62 had diabetes mellitus (18.6%). The overall rate was
males 10% against 8.7% in females .
Clinical Manifestations :
Tuberculosis supervening on patients having preexisting
diabetes often is devoid of the early warning signs and symptoms. The patient may
attribute to  malaise, loss of appetite and weight loss to an exacerabation of his
diabetic state. The patient usually attributes ”cough with expectoration and fever”
to frequent respiratory tract infection he is prone to develop. Eventually, the
patients with diabetes attributes these alterations to improper control of diabetes
mellitus and the onset of tuberculosis is masked long enough untill the disease to
get established & the florid signs and symptoms become manifest. Similarly
tuberculosis patients attribute their worsening of their conditions to tuberculosis
and hence they fail to suspect diabetes mellitus.
Tuberculosis should be suspected in patients with diabetes who has
fever, weight loss, generalised fatiguability that cannot be fully explained by poor
diabetic control alone.
Tuberculosis can involve any organ system, but most common organ
for primary lesion is lung and it is the principle organ involved. Symptoms may be
absent during the early phase of development of lesion as well as in advanced
disease. Appearance of symptoms depends not only on the extent of the disease,
but primarily on the
 host- parasite relationship,
 the state of natural resistance
 the number and virulence of the infective organism
General or constitutional symptoms occurs  due  to release of products
from the diseased foci into the bloodstream and include lassitude, loss of appetite
and weight, anaemia, sweating, tachycardia, pyrexia, digestive disturbances. The
other common symptoms of tuberculosis include cough, hemoptysis, chest pain
and dyspnoea.
Common presentation of pulmonary tuberculosis:
 Symptoms free and radiologically diagnosed.
 Productive or non productive cough.
 Generalised fatiguability.
 Loss of weight.
 Repeated attacks of URI.
 Tuberculous pneumonia.
 Hemoptysis
Duration of Diabetes :
The time gap between diagnosis of diabetes and the onset of
symptoms of pulmonary tuberculosis was found to range from several months to
16 years with a mean interval of  7 years. One other study also noted similar
relation between diabetes and onset of pulmonary tuberculosis.
In 26.7% cases, tuberculosis is diagnosed before DM , in 46.7%
cases after diabetes mellitus and in 18.6% at the same time. Younger individuals
with less BMI, uncontrolled type 1 diabetes are prone to develop TB.
However, some studies didn’t show any relationship between
onset of pulmonary TB and duration of diabetes.
Cigarette Smoking :
In Tuberculous patients of age more than 40 years, there are
increased number of smokers than non-smokers.
Clubbing and Pulmonary Tuberculosis
The prevalence of clubbing in pulmonary tuberculosis, as
reported by various studies varied from less than 1% to 90%..Finger clubbing was
shown to accompany with extensive- pulmonary damages evidenced by larger
cavities on the chest X-ray and had more chance of hemoptysis. Gross clubbing
only occurs in patient with long standing tuberculosis24.
The individuals having finger clubbing are undernourished
compared with the individuals not having. It is due to the severity of infection
resulting in protein catabolism..  Immunodeficiency due to malnutrition cause
damage to the lung , due to extensive TB or due to secondary infection. Clubbing
of fingers is a marker of destructive disease in PTB.
Haematology in Pulmonary Tuberculosis :
A normocytic, normochromic anaemia was a predominant
feature in pulmonary tuberculosis. Astudy done in Kashmir, it is found that 87.76%
of TB patients were anaemic. (14.26% - mild anaemia, 16.34% -moderate and
57.16% -severe anaemia.) Anaemia was normocytic hypochromic and normocytic
normochromic type. Haemoglobin range was from 4 gm/dl to 13.4 gm/dl.
Erythrocyte sedimentation rate (ESR) is a non-specific
reaction and is a general manifestation of disease or tissue destruction. It is
therefore, not of specific diagnostic value in tuberculosis. Rate of ESR indicates
only the degree of activity of the infectious process. Repeated value of ESR has
more significance than a single value and is a prognostic indicator in chronic PTB
on treatment.
WBC – Widespread pulmonary shadows on a chest x ray with
normal WBC suggests a diagnosis of PTB than a lung abscess or pneumonia.
Severity of Diabetes
A correlation between the severity of diabetes mellitus and the
presence of active tuberculosis is suggested by the fact that 5.3% of those whose
had diabetes required more than forty (40) units of insulin daily had the disease in
active form. Diabetics with severe degree of hyperglycemia was shown to
increase the incidence of pulmonary tuberculosis.
In patients of diabetes having pulmonary tuberculosis, majority
had moderate or severe type of diabetes5.
Astudy of 170 cases of Diabetes, 30.6% incidence of pulmonary tuberculosis was
found. Greater than 100 units of insulin daily dose was required in 87.7% of
tuberculous diabetics and in 24.2% of non-tuberculous diabetics.
Lower Lung Field Tuberculosis :
Lower lungfield TB are classified as tuberculous disease seen
below the imaginary line traced across the hila and including the parahilar region
on a standard PA chest radiograph.
Reason for developing for lower lung field tuberculosis are
transbronchial perforation of hilar lymphnode,and disseminates to adjacent
structure.
Thus, lower lung field disease occurs due to continuation of the
primary tuberculous infection or soon afterwards in the pathogenesis of lower lung
field tuberculosis.
It can also results from (1) poor ventilation, (2)coastal breathing and
(3)retrograde lymphatic flow from the involved hilar nodes. The  first site of
disease is the apical segment of lower lobe and upper and posterior part of lower
lobe are second most vulnerable site.
The percentage of lower zone TB in diabetics with tuberculous
was 13.91%. Right lower lobe was found to be involved more common than the
left.
Radiology in Pulmonary Tuberculosis with Diabetes Mellitus :
Tuberculous involvement tend to be more severe in diabetics
compared to non-diabetics. Most tuberculous diabetics are admitted for treatment
in the advanced stage of tuberculosis.
In a study, it was observed that 77.8% of patients had severe stage
of tuberculosis, 18.5% had moderately severe and only (3.9% ) had minimal lesion.
Uncontrolled cases of diabetes mellitus with tuberculosis, number of zone in the
lung involved was higher as compared to control series31.
The cavitary lesions were observed in 70% of tuberculous
diabetics as compared to non-tuberculous diabetics. In 76.3% tuberculous diabetics
with cavity, the evidence of activity was noted. Fibrosis and calcification were
seen in significantly less number of tuberculous diabetics cases. Coexistence of
diabetes with pulmonary tuberculosis causes the flaring of lesions and also
interferes in healing process
Diagnosis of Pulmonary Tuberculosis :
1. Sputum examination: Is of more significance
 In PTB diagnosis
 For monitoring treatment response
Sputum examination can be done by Ziehl-Neilsen method
/fluorescence method of which the fluorescence method is used for
quick screening of more number of samples. Advanced disease and
patients with multiple cavities show more sputum smear positivity
than in less advanced PTB.
2. Sputum culture: Culture is positive after 3 – 8 weeks (Lownstein –Jensen
medium). Bactec a radiometric culture method allows for rapid diagnosis within 2-
6 days. Sputum culture should be carried out in whom the diagnosis of TB is
doubtful.
3. Radiological features indicative  of tuberculosis: Following are the features of
PTB on chest X-ray :
 Upper zone opacities.
 Nodular / patchy opacities
 Calcification
 Cavity
 Bilateral upper zone opacities.
 Persistent opacitites (several weeks)
Characteristic Radiographic Appearances :
Shadows that are soft confluent are due to an exudative process and
mimic a simple pneumonia. Fibrosis is suggested by linear shadows that cause
distortion of mediastinum, trachea, fissures and diaphragm. A common finding on
chest X-ray is presence of fibrotic shadows in bilateral upper zone, elevation of
pulmonary hila and shrinkage of upper lobes.
Healed disease is indicated by calcification although reactivation
can occur in old calcification. Upper lobe apical and posterior segment is most
commonly involved but rarely the disease can be limited to the upper lobe anterior
segment.
Cavitation :
A draining bronchus with a valvular process results in cavity whose
wall is initially irregular with caseous material that later on transforms into thin
smooth walled cavity as the caseaous material is reabsorbed or coughed out.
Tuberculoma results when a cavity is blocked and filled up with caseous
purulent material. Persistent cavities can be present despite chemotherapy and get
transformed into an aspergiloma. Prolonged illness and presence of nodular or
patchy infiltrates and areas of atelectasis helps differentiate tuberculous and non-
tuberculous cavities.
CT helps in confirming the diagnosis on the basis of presence of cavity and
satellite lesions and detecting calcifications in a doubtful lesion.
Assessment of Activity :
It is tough to determine if a lesion needs treatment or further assessment.
1. Sputum positivity suggests active lesion and treatment is absolute.
 A radiographically detected lesion associated with symptoms of hemoptysis,
weight loss, fatiguability, loss of appetite and cough indicates an active
lesion.
 Persistent crepitations suggest an active lesion.
 Cavity or a soft shadow that is widespread and that extends on serial chest
films is highly indicative of activity.
Treatment of Pulmonary Tuberculosis
First line drugs in the management of PTB are
Isoniazid ,Rifampicin, Ethambutol Pyrazinamide
.These drugs were advised on basis of their lower rate of causing drug
resistance,bactericidaland sterilizing activity
Recommended dosage of drug for initial treatment of tuberculosis in adults:
 Isoniazid5 mg/kg, maximum 300 mg
 Rifampicin 10 mg/kg, maximum 600 mg
 Pyrazinamide20 – 25 mg/kg, maximum 2 gm
 Ethambutol 15 – 20 mg/kg.
Second line drugs are used only in resistant cases due to their low
efficacy and higher side effects.
Second line drugs include:
 Streptomycin
 Kanamycin
 Amikacin
 Capreomycin
 Ethionamide, Cycloserine, PAS
 Fluoroquinolone antibiotics has become the most commonly used second
line drugs.
Six months regimens (short course) is subdivided into an initial/
bactericidal phase and continuation/sterilizing phase. In  the bactericidal phase,
most of tubercle bacilli is destroyed and  symptoms recovers and the patients are
non infectious.
Continuation phase is needed for eradicating persistant mycobacteria and for
preventing relapse. The treatment regimen of choice for virtually all forms of
tuberculosis consists of a two months bactericidal phase of isoniazid, rifampicin,
pyrazinamide and ethambutol followed by a four months continuation phase of
isoniazid and rifampicin.
Treatment is prolonged for a period of 9 months in those who
show sputum culture positivity after 2 months of treatment and in cavitary PTB. In
those who are prone for vitamin B 6 deficiency such as pregnant and lactating
mothers, chronic diseases ( diabetes, renal failure, HIV), malnourishment and
alcoholics pyridoxine ( 10 – 25 mg/day) is added in order to avoid INH induced
neuropathy.
Multidrug Resistant Tuberculosis And Its Association With DM
In a study conducted in Bellevue chest hospital, New York, it was
reported that is significant relation between DM and multidrug resistant
tuberculosis. 3.6% (17cases) of the cases with tuberculosis diabetic patients
hasMDR TB compared to Ten % (10 cases) in control group.
In a study conducted in Chennai, it was reported that 26% of cases
had multidrug resistant tuberculosis. Single drug resistance occurs due to direct
monotherapy ( ingestion of only one drug) or indirect monotherapy ( multiple
drugs of which the bacilli is sensitive to only one). Individuals with secondary type
of drug resistance can transmit the bacilli to others who are then referred as
primary drug resistance. This type of transmission is favoured by HIV in which
deficient infection control measures and late diagnosis leads to rapid progression of
the disease.
Treatment is to be started with 3 drugs that are sensitive against
the bacilli if chance of multi drug resistance is high (eg. Immigrant from high drug
resistant country, contact with an MDR TB patient, relapse patient)
Sputum culture negativity at 6 or 12 months is required to stop
therapy.
Special aleration in treatment of Tuberculosis and Diabetes:
1. Protein and calorie rich diet (2150 - 2500 cal/day)
 To meet the need for negative nitrogen balance.
 To avoid reactivation or infection.
 To increase insulin production.
2. Effect of anti-tuberculosis drugs in diabetes mellitus.
 Rifampicin
 Interacts with P450 cytochrome oxidase enzyme and accentuates
sulphonylurea metabolism.
 Insulin need is increased
 Absorption of glucose in intestine is increased
 INH
 Opposes sulphonylurea action
 Rare incidence of pancreatitis.
 Biguanides
 Weight loss and Appetite loss
 Glucose malabsorption.
3. Selection of anti-diabetic drugs:
To counteract the calorie rich diet and also due to incidence of
pancreatic TB, Oral hypoglycemic (Biguanides and sulphonylurea) that are
pancreatic stimulants are avoided.
To lower any degree of blood sugar within short interval of time
Insulin is the best choice because hyperglycemia will affect the anti-tuberculosis
response.
Insulin also helps has anti-flammatory response and helps
in healing process.
MATERIALS AND METHOD
DURATION OF STUDY :  1 years ( OCTOBER 2015 –SEPTEMBER 2016)
POPULATION TO BE STUDIED : 100
STUDY GROUP :10 TO 75 Yrs age group .
STUDY SETTING : Dept of General Medicine , Chengalpattu Medical
College and Hospital Chengalpattu.
INCLUSTION CRITERIA
 Includes all old and newly diagnosed cases of diabetes.
 Type 1 and type 2 DM are included.
EXCLUSION CRITERIA
 Diabetic patients with HIV patients are also excluded.
 Other types of Diabetes including GDM.
 Diabetic patients on steroids and immunosuppresants
 Critically ill patients
 Patients not given consent
STUDY POPULATION :
Diabetic patients in diabetic clinic, wards of Department
of medicine,
Chengalpattu Medical College and Hospital
RESULTS
Number of  TB cases -100.
Number of males- 70 (70%)
Number of females- 30 (30%)
TABLE 1: SEX WISE DISTIBUTION
M:F Ratio -2.3:1
DM
AGE LESS THAN
40 YEARS - 22%
AGE MORE THAN
40 YEARS - 78%
MALES FEMALES TOTAL
70 30 100
Table 2 represents the distribution of patients on the basis of age. The peak
occurence of PTB is noted in age > 50 years. The maximum occurrence is noted in
the age group 50-59 years of age and 60-69 years of age.
Mean age among males – 55.9
Mean age among females – 47.0
Table 2 : Age sex distribution
AGE
GROUPS
MALE FEMALE TOTAL PRECENTAGE
10 - 19 1 1 02 02
20-29 2 2 04 04
30-39 9 6 15 15
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GRAPH-1 SEX RATIO
SEX RATIO
40-49 16 6 22 22
50-59 15 10 25 25
60-69 21 3 24 24
70-79 6 2 08 08
Total 70 30 100 100
Mean age       55.9                       47.0 51.4
± SD ± 11.4 ± 13.2 ± 12.5
Range 34 – 76 19 – 70 19 – 76
Table 3 shows that the predominant clinical features are anorexia (82%), cough
(77%), weight loss (44%), pyrexia (42%). Other clinical features are night sweats
(31%), hemoptysis (12%), shortness of breath (20%), chest pain (16%).
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Table 3: CLINICAL FEATURES
CLINICAL
FEATURES
M F LESS THAN
40 YRS
MORE THAN
40 YRS
TOTAL
ANOREXIA 58 26 19(90) 65(82) 84
COUGH 52 22 13(62) 61(77) 74
PYREXIA 41 17 16(76) 40 (42) 58
SHORTNESS
OF BREATH
18 3 5(23) 16(20) 21
WEIGHT
LOSS
34 13 12(57) 35(44) 47
HEMOPTYSIS 7 5 3(14) 9(12) 12
CHEST PAIN 15 4 7 (33) 12(16) 19
NIGHT
SWEATS
23 12 10(47) 25(31) 35
In Table 4, 20% of cases had a old history of  TB. 15% of cases
were hypertensives and 8% of  cases had IHD
Table 4 : Past history
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ISCHEMIC
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5 8 8
HYPERTENSION 11 4 15
Family h/o tuberculosis-15%
In table 5, out of the 70 males, 48 patients (68.5%) are smokers.
Table 5 : Smoking incidence:
TOTAL NO.OF CASES M F
TOTAL NO OF CASES 70 30
TOTAL NO OF 48 0
SMOKERS
PERCENTAGE 68.5% 0
In table 6 , 12 cases (12%) showed clubbing 9 cases of which had severe TB
shown by multilobe involvement and extensive TB.
Table 6 : Clubbing incidence:
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Chart 4-Incidence of smoking
Smokers
NonSmokers
TOTAL NO. OF CASES NO. OF CASES WITH
CLUBBING
PERCENTAGE
100 12 12
cervical lymphadenopathy is seen in 8 % of the patients
As seen in table 7, 55% of the cases has duration of diabetes between six to ten
years and 17% of the cases had a duration of diabetes between two to five years
and in 6% of the cases less than one yr. 21% of the cases has duration greater than
ten yrs.
Table 7 : DURATION OF DIABETES
Diabetes –time period No of individuals % (Percentage)
Less than one yr 6 6
Two-five yrs 17 17
Six-ten yrs 55 55
More than ten yrs 21 21
TOTAL 100 100
Mean - 6.8
± SD - ± 3.6
Range - 2mon - 15yrs.
Table 8 shows a relation between FBS and PTB. 43% of cases
have FBS between 200-299 mg/dl; 28% have values between 149-199 mg/dl; 24%
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of cases have mean FBS of  >300 mg/dl and 5% of cases have FBS between 126-
149 mg/dl.
Table 8 : FBS values in TB-DM patients
FBS (FASTING BLOOD
SUGAR) mg/dl
NO.OF PATIENTS PERCENTAGE
126-149 5 5
149-199 28 28
200-299 43 43
≥300 24 24
Mean - 236.4
± SD ± 65.5
Range 120 – 380
528
43
24
Chart-6 Fasting blood sugar in tuberculous
diabetes
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Table 9 shows relation between PPBS values in TB patients. 15% of the cases
have values between 201-249 mg/dl; 36% have values ranging from 250-349
mg/dl; 49% of the cases had values above 350 mg/dl.
Table 9 : DMTB -PPBS
PPBS(POST PRANDIAL
BLOOD SUGAR)
NO OF CASES %(PERCENTAGE)
201-249 15 15
250-349 36 36
≥ 350 49 49
Mean - 351.5
± SD - ± 67.9
Range - 230 – 460
In table 7, 55% of cases showed anemia of which 23% had mild anemia (9-11
gm%) ; 25% of cases had HB between 6-9 gm% (moderate anemia); 7% of the
cases had hemoglobin less than 6 gm% (severe anemia).
Table 10 : Haemoglobin
HEMOGLOBIN VALUE
(gm%)
NO OF CASES %(PERCENTAGE)
>11 45 45
9-11 23 23
6-9 25 25
<6 7 7
TOTAL 1OO 100
Range 5 - 13
Table 11 shows leukocyte count of mean – 10760 with SD of
2401. The lymphocyte percentage mean – 43.5 with SD of  3.8.
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Table 11 : Leukocyte count and Lymphocyte%
Mean + SD RANGE
LEUCOCYTE COUNT 10760 + 2401 3600 -16000
LYMPHOCYTE% 43.5 + 3.8 34 - 54%
Table 12 shows ESR values in TB patients. 9% of the cases showed an ESR value
of >100 mm/hr; 48% of cases showed ESR between 50-99 mm/hr; 29% of cases
were with ESR 21-49 mm/hr; remaining 14% had an ESR of <20 mm/hr. 86% of
the total cases had a raised ESR.
Table 12 : ESR
Erythrocyte sedimentation
rate (mm/hr)
NUMBER OF
PATIENTS
%
< Twenty(20) 14 14
21-49 29 29
50-99 48 48
≥100 9 9
TOTAL 100 100
Mean ± SD 50.8 ± 26.5
Range 13 – 114
Table 13 shows that out of 100 cases 86% of patients less than 40 years and 54%
of patients more than 40 years showed sputum positivity.
Table 13 : Sputum AFB – results
SMEAR-
SPUTUM
LESS THAN
40YRS
MORE THAN
40YRS
TOTAL
POSITIVE 18(86%) 43(54%) P=0.01
SignificantNEGATIVE 3(14%) 36(46%)
86
54
14
46
0
10
20
30
40
50
60
70
80
90
100
<40 yrs >40yrs
pe
rce
nta
ge
Age groups
Chart-8 Sputum AFB-results
Positive
Negative
Table 14 shows the predominantly involved side. In 39% of
patients right side involvement was seen. In 30% of patients left side involvement
was predominant and in 31% both sides were involved.
Table 14 : Predominantly involved side (left/right/both sides):
PREDOMINANTLY
INVOLVED SIDE
AGE LESS
THAN 40
AGE MORE
THAN 40
TOTAL
M F M F
RIGHT 5 3 25 6 39
LEFT 3 1 20 6 30
BOTH SIDES 4 5 13 9 31
In table 15, 34% of patients showed lower zone changes out of which 4 patients
were below 40 years and 30 patients were in the age group more than 40 years.
Table 15 : DM-TB-lower lobe involvement
PATIENTS AGE AGE LESS THAN
40
AGE MORE
THAN 40
P VALUE
NO OF
PATIENTS
4 30 P <0.05 -
SIGNIFICANT
4
30
Chart -9 lower lung field tuberculosis
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Table 16 shows radiographic features in DM-TB. 55% of cases
showed cavity; 36% of the cases showed fibrotic lesions; 36% of cases had
infiltration; pleural effusion was seen in 23%; 6% showed consolidatory changes;
5% had hydropneumothorax; aspergilloma was associated in 3% of cases; 2%
showed bronchiectasis.
Table 16 : Radiological results
PATTERN OF
LUNG
INVOLVMENT
M F AGE
LESS
THAN 40
n(%)
AGE
MORE
THAN 40
n(%)
TOT
AL
P
VAL
UE
FIBROSIS 23 9 2(10) 29(36) 31 0.002
CAVITY 35 19 10(47) 44(55) 54 0.04
CONSOLIDATIO
N
6 3 3(14) 6(6) 9 0.59
PLEURAL
EFFUSION
6 4 4(23) 5(6) 10 0.29
HYDROPNEUMO
THORAX
4 0 0 4(5) 4 0.23
BRONCHIECTAS
IS
3 1 1(4) 2(2) 4 0.69
INFILTRATION 20 16 7(33) 29(36) 31 0.89
ASPERGILLOMA 3 0 0 3(3) 3 0.49
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DISCUSSION
100 PTB-DM patients were clinically and radiographically
evaluated. A significant relation between TB and DM is suggested by high
occurrence of TB in diabetics.
In the study conducted by us, 70% are male population and
30% are females. The ratio between males and females is2.3:1.
A higher prevalence as well as incidence of TB in male
population is noted in several other studies also with male to female ratio between
3:1to5:1.
Desmukh et al studied 2434 cases of PTB and reported that
62.9% of cases to be males and 37.1% of cases to be females. Of the 138 DM-TB
patients, 72.4% of patients were males and 27.53% of them were females.
A similar M:F ratio was shown by Patel JC.  Of the 179 patients
studied by him males constituted 76% and females constituted 24%.
A study by Morris et al shows a higher incidence of DM-PTB in
male population than female population.
Tripathy and Kar observed that males constituted 78% of the total
patients.
It is made out that males are more susceptible than females for
pulmonary tuberculosis associated with diabetes. ICMR [Anon 1958] conducted a
national survey and presented its salient findings. Ibrahim Kareem Khalil
In a study conducted by  Ibrahim kareem khalil ,”The
relationship between tuberculosis and Diabetes Mellitus in patients” had shown
higher incidence among males, with a male to female ratio of about 5:1
A similar observation of higher occurrence of DM-PTB is noted
among males in all the above mentioned studies including ours.
Reason for increased occurrence of DM-TB in males :
1. Higher incidence of both diseases is seen among males.
2. Increased hospitalization of males.
In our study, the number of cases over the age of  forty were 78% and
peak incidence was in the age groups of 50 – 59 and 60 – 69 years. 57% of the
total cases were in this age groups.
STUDY Age group
showing peak
incidence of PTB
Percentage
Deshmukh >45 82.6%
Brijkishore >50 57.1%
Philips >50 52%
In the study conducted by us, greater occurrence of DM-PTB is
noted among age group more than 50 years. 57% of total patients belong to this
age group.
In a study conducted by  Ibrahim kareem khalil , “The relationship
between tuberculosis and Diabetes Mellitus in patients. Age of the patients ranged
between 24 - 75 year -old (5l.84 10.71 year-old) . 32patients (64% of the sample)
were 40-59 year- old.This  study also shows the increased incidence after 40 years
of age
Major clinical features observed in study conducted by us are
anorexia (82%), cough (77%), weight loss (44%), pyrexia (42%). Other clinical
features are night sweats (31%), hemoptysis (11%), shortness of breath (20%),
chest pain (16%).
In a DM-TB study done in Ethiopia, 3 most common clinical features are:
 Pyrexia (80.5%)
 Increased sweat (80.4%)
 Cough (70.5%)
 In the study done by us, there is a higher incidence of anorexia, cough, loss
of weight.
 Past H/O TB was seen in 20% of patients
 15% of the cases were hypertensives
 Family H/O TB was seen in 15% of cases.
48 among 70 males (68.5%) had history of smoking. There is
increased incidence of pulmonary TB in smokers compared to non smokers in
either sex of age more than 40 years.
As the majority of males (68.5%) are smokers, smoking is a major risk
factor in development of TB.
12% of patients in the study done by us had finger clubbing of whom
75% had severe extensive TB as proven clinically and radiographically. Wide
differences were noted in the prevalence of clubbing by different observers.
STUDY PREVALENCE OF CLUBBING
WEIRMAN 1%
NEUFELD 90%
MA CFA RL ANE 21%
Finger clubbing occurs in those with chronic TB and extensive lung damage and is
thus a marker for extent of destruction.
Similar observation between clubbing and extensive TB was noted in
the study done by us.
Our study Pavan Malhotra study
Anemia 55% 88.76%
Mild 23% 13.26%
Moderate 25% 17.34%
Severe 7% 58.16%
.
The difference in % of anemia may be due to
 Method of choosing the patients
 Geographical distribution
 Food habits
In the study done by us 9% of the cases showed an ESR value of
>100 mm/hr; 48% of cases showed ESR between 50-99 mm/hr; 29% of cases were
with ESR 21-49 mm/hr; remaining 14% had an ESR of <20 mm/hr. 86% of the
total cases had a raised ESR.
Erythrocyte sedimentation rate is an indicator of widespread illness or
tissue damage and thus can be increased in various situations. Therefore ESR is not
a specific test and does not possess much diagnostic significance. To be of value
multiple readings are needed. It is also a marker of chronicity of disease in patients
on treatment.
The mean total leukocyte count in the study conducted by us is
10760. Cases with extensive TB had normal leukocyte count and vice versa. Hence
there is no significant relation between leukocyte count and extent of TB.
55% of the cases has duration of diabetes between six to ten years
and 17% of the cases had a duration of diabetes between two to five years and in
6% of the cases less than one yr. 21% of the cases has duration greater than ten
yrs.It has been shown that diagnosis of DM occurred before TB development in
most cases.
Tripathy et al observed that the time gap between DM detection and
PTB onset differed from several months to 16 yrs.
Duration of diabetes play an important role in the development of
chronic diabetic complications that may alter the physiology of system. Diabetic
autonomic neuropathy can lead to abnormal basal airway tone due to alteration in
vagal pathways and thus cause a reduced bronchial reactivity and broncho dilation
and thus can play an important role in creating this higher risk of respiratory tract
infection including tuberculosis among diabetic patients .
In a study conducted by  Ibrahim kareem khalil ,”The relationship
between tuberculosis and Diabetes Mellitus in patients” 56% of the sample
included in this study was either newly diagnosed or had diabetes for less than 10
years.
Long standing DM is associated with higher risk of infections and
hence time period of diabetes is important.
43% of cases have FBS between 200-299 mg/dl; 28% have
values between 149-199 mg/dl; 24% of cases have mean FBS of  >300 mg/dl and
5% of cases have FBS between 126-149 mg/dl.
15% of the cases have PPBS values between 201-249 mg/dl; 36% have values
ranging from 250-349 mg/dl; 49% of the cases had values above 350 mg/dl.
In two different studies conducted by Sach deva AK and Deshmukh PA ,
there was a higher occurrence of PTB in those with poor glycemic control.
In a study conducted by  Ibrahim kareem khalil ,”The relationship
between tuberculosis and Diabetes Mellitus in patients” FBS in TB cases varies
between 82-396 mg/dl and it had shown that tuberculosis associated with
hyperglycemia.
Out of 100 cases 86% of patients less than 40 years and 54% of
patients more than 40 years showed sputum positivity. P value is 0.01.
A study conducted by  Ibrahim kareem khalil ,”The relationship between
tuberculosis and Diabetes Mellitus in patients” 38 patients (76% of the sample )
had sputum smear positive and it had shown that higher incidence of  sputum
positive in diabetic patients.
Similar to other studies though smear positive cases were less among age
group >40 years cavitation and fibrosis was more in this group. Inspite of
increased bacterial count in cavitary lesions rate of smear positivity seems to be
less in these cases due to fatiguability of muscles as a result of poor glycemic
control and weak expectoration.
This is in similarity with the other studies like
1. Quazi et al study conducted during  2006, where “bilateral lesions were
found in 27% of DM-TB”.
2. Ind. J .Med .res., July 2009.,Young et al., “ concomitant TB and DM is
associated with more severe features including increased lung cavitations.”
In 39% of patients right side involvement was seen. In 30% of patients left side
involvement was predominant which combinedly accounts to 69% . 31% of cases
had lesions bilaterally.
34% of patients showed lower zone changes out of which 4
patients were below 40 years and 30 patients were in the age group more than 40
years.  This accounts to a P value less than 0.05 that is significant.
In two different studies conducted by Bacakoglu F et al and
Ravindran P et al lower lobe involvement was higher among female sex and those
aged more than 40 years which is the same in the study conducted by us.
The radiographic features in DM-TB showed that 55% of cases
showed cavity; 36% of the cases showed fibrotic lesions; 36% of cases had
infiltration; pleural effusion was seen in 23%; 6% showed consolidatory changes;
5% had hydropneumothorax; aspergilloma was associated in 3% of cases; 2%
showed bronchiectasis.
Cavitary lesions (53%) were the most common type of lesions noted
followed by fibrosis (39%), infiltration (38%) in the age group of >40 yrs
Radiographically, cavity, opacification and pleural effusion are more
common than reticulo-nodular pattern in TB-DM patients.
Perez Guzman et al observed that multiple cavities involving lower lobe is more
common in TB-DM patients.
A study on Radiological Pattern of Pulmonary Tuberculosis in Diabetes
Mellitus by Qazi M.A.1, Sharif N.2, Warraich M.M.3, Imran A.4 Haque I.U.5,
Attique M.U.H.6, Gardezi M.A.7, Chaudhary G.M. had shown Out of 150 films,
in 84 right lung was involved, in left lung about 39 and bilateral lesion found in 27
films.
In TB-DM patients there is increased incidence of caeseation and cavitation
but with minimal involvement of pleura which the same in the study done by us.
Consolidation, bronchiectasis, aspergilloma and hydropneumothorax are the
other radiographically detected lesions.
Our results show similar correlation with other mentioned studies with
respect to side, site, extent of lung changes and radiographical features.
CONCLUSION
 Male population accounted to 70% and females to 30% with M:F ratio of
2.3:1 of which 78% of the individuals are in the age group of more than 40
years.
 The major clinical presentation is anorexia (82%), cough (77%) and loss
of weight(44%).
 .Past H/O TB is seen in 20% of cases and family H/O TB in 15%.
 Out of the total male patients , 68.5% are smokers. 12% of total cases had
clubbing of which 85% was associated with advanced stage of TB proven
radio graphically and clinically.
 Mean duration of diabetes in TB patients is 6.8 years.
 55% of cases have anemia out of which 7% are severely anemic.
 ESR >50 mm/hr is noted in 57% of cases.
 The mean FBS value is 236.4 mg/dl and the mean PPBS value is 351.5
mg/dl.
 Sputum positivity in age less than 40 years is 86% and in age more than 40
years is 54%.
 Lower lobe involvement is noted in 34% cases. 39% of cases have
predominant right side involvement whereas 30% have left side
involvement. Bilateral involvement is seen in 31% of cases.
 The most common lung change noted in both less than and more 40 years
age group is cavitation (55%). The second most common pattern in age more
than 40 is fibrosis and infiltration whereas in age less than 40 fibrosis
accounts for a lesser percentage.
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SCREENING OF TUBERCULOSIS IN DIABETES MELLITUS PATIENTS
PROFORMA
Sl. No. : O.P. / I.P. No.:
Date : Hospital : BH/CGH
Name : Religion :
Age : Marital status :
Sex : Socioeconomic :
Address : Occupation :
Presenting complaints :
Cough :
Expectoration :
Fever :
Night sweats :
Hemoptysis :
Chest pain :
Breathlessness :
Anorexia :
Loss of weight :
Others :
Past history :
Tuberculosis :
Diabetes :
Hypertension :
Ischemic heart disease :
Family history :
H/o tuberculosis :
H/o diabetes :
Others :
Personal history :
Smoking :
Alcohol :
Appetite :
Sleep :
Diabetes history :
How diabetes mellitus was diagnosed :
Duration :
Treatment :
Treatment history :
Previous H/o anti TB drug treatment :
Duration :
PHYSICAL EXAMINATION :
General examination :
Pallor :
Cyanosis :
Icterus :
Clubbing :
Lymphnodes :
Pedal edema :
Respiratory rate : Pulse : B.P. :
SYSTEMIC EXAMINATION :
Respiratory system :
Upper respiratory system :
Lower respiratory system :
Inspection :
Shape of the chest :
Tracheal position :
Respiratory movements :
Drooping of shoulder:
Palpation :
Trachea :
Apical impulse :
Movements of the chest :
Tenderness of intercostal space :
Vocal fremitus :
Percussion : Right Left
Supra clavicular :
Clavicular :
Infra clavicular
Mammary :
Axillary :
Infra axillary :
Supra scapular :
Inter scapular :
Infra scapular :
Auscultation :
Breath sounds :
Additional sounds :
Vocal resonance :
(in the above areas)
Cardiovascular system :
Abdomen :
Nervous system :
INVESTIGATIONS :
Blood examination :
Hb% :
T.C :
D.C :
ESR :
RBS :
FBS :
PPBS :
Sputum AFB :
Sputum culture :
Chest x-ray findings :

